First whole body FDG-PET scan and MRI before the start of the treatment. Second whole body
FDG-PET scan and MRI after the end of the treatment. On a basis of patient, comparison
between PET and MRI will be done tumoral site by site. Sensitivity, Specificity will be
estimated for both techniques. In case of discrepancy, another imaging method or biopsy (if
easy to perform) will be serve as standard of reference. Kappa coefficients and Mc Nemar
test will be performed to compare the two methods. FDG = fluorodeoxyglucose FLUCIS®
(Schering-CisBio® international)
Interventional
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Olivier Couturier, MD
Principal Investigator
Nantes University Hospital
France: Ministry of Health
BRD/04/6-H
NCT00200668
March 2005
December 2006
Name | Location |
---|